MedMeetings – Translate Knowledge Into the Practice

EASD 2025

Mortality, Kidney, and Safety Outcomes with SGLT-2 Inhibitors vs DPP4 Inhibitors in Patients with Type 2 Diabetes Treated with Systemic Glucocorticoids

The research study was presented on Monday, September 15th, 2025

Mukul Ayachit March 12, 2026

EASD 2025

Precision Medicine in Type 2 Diabetes: Targeting GLP1 Receptor Agonist and SGLT-2 Inhibitor Combination Treatment for Kidney Protection

The comprehensive study was presented on Monday, September 15th, 2025

Mukul Ayachit March 9, 2026

EASD 2025

Pharmacodynamic Effects of Oral Small Molecule GLP-1 Agonist TERN-601 in Healthy Participants with Obesity or Overweight

A phase 1 clinical trial presented at the 61st European

Mukul Ayachit March 6, 2026

EASD 2025

Association between Grip Strength and Risk of Metabolic Multimorbidity in Chinese Adults: A Prospective Cohort Study

A comprehensive analysis from the China Health and Retirement Longitudinal

Mukul Ayachit February 27, 2026

EASD 2025

Machine Learning Identifies Glypican 4 as Key Predictor of 5-year Mortality in Heart Failure Patients with Prediabetes or Diabetes

A pioneering study has demonstrated that machine learning algorithms can

Mukul Ayachit February 26, 2026

EASD 2025

Mortality and Persistence in Therapy in Elderly Patients Treated with Gliflozines vs Incretins

A new study from the University of Pisa has revealed

Mukul Ayachit February 20, 2026

Latest Articles

Societies

Speciality